Rhythm Pharmaceuticals, Inc. (RYTM)
109.99
+0.13
(+0.12%)
USD |
NASDAQ |
Nov 13, 10:51
Rhythm Pharmaceuticals Net Income (Annual) : -196.54M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -196.54M |
| December 31, 2024 | -260.60M |
| December 31, 2023 | -184.68M |
| December 31, 2022 | -181.12M |
| December 31, 2021 | -69.61M |
| December 31, 2020 | -134.00M |
| December 31, 2019 | -140.73M |
| Date | Value |
|---|---|
| December 31, 2018 | -74.06M |
| December 31, 2017 | -37.58M |
| December 31, 2016 | -29.07M |
| December 31, 2015 | -12.00M |
| December 31, 2014 | -6.493M |
| December 31, 2013 | -21.43M |
| December 31, 2012 | -18.13M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| BioMarin Pharmaceutical, Inc. | 348.90M |
| Cytokinetics, Inc. | -784.96M |
| Exelixis, Inc. | 782.57M |
| Ionis Pharmaceuticals, Inc. | -381.39M |